pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ADARx Pharmaceuticals Inc · news · pharmadog
← back to ADARx Pharmaceuticals Inc
News mentioning ADARx Pharmaceuticals Inc
10
stories
9d
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
9d
Alnylam alumni lead RNAi biotech City Therapeutics to IPO filing
endpoints
9d
ADARx prices $446.3M Nasdaq debut, continuing industry's IPO momentum
endpoints
10d
ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
fiercebiotech
10d
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
12d
2026 IPO blitz continues with 4 new biotech filings
biospace
13d
ADARx targets $319M IPO as TRexBio, Retension join filing queue
endpoints
26d
Moonwalk reloads with $70M and new RNAi prospects for obesity
biopharma dive
28d
AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies
fiercebiotech
29d
AbbVie-allied ADARx aims for IPO with three drugs in the clinic
endpoints
